O	0	1	A
B-intervention	2	6	text
I-intervention	7	14	message
I-intervention	15	27	intervention
O	28	30	to
O	31	38	support
O	39	44	women
O	44	45	'
O	45	46	s
B-condition	47	55	physical
I-condition	56	59	and
I-condition	60	66	mental
I-condition	67	73	health
O	74	79	after
O	80	86	breast
O	87	93	cancer
O	94	104	treatments
O	105	106	(
O	106	113	EMPOWER
O	113	114	-
O	114	117	SMS
O	117	118	)
O	118	119	:
O	120	121	a
O	122	132	randomised
O	133	143	controlled
O	144	149	trial
O	150	158	protocol
O	158	159	.

O	160	166	Breast
O	167	173	cancer
O	174	176	is
O	177	180	the
O	181	185	most
O	186	192	common
O	193	199	cancer
O	200	209	diagnosed
O	210	212	in
O	213	218	women
O	219	228	worldwide
O	228	229	.

O	230	232	In
O	233	242	developed
O	243	252	countries
O	252	253	,
O	254	256	80
O	256	257	-
O	257	259	90
O	259	260	%
O	261	263	of
O	264	269	women
O	270	274	will
O	275	282	survive
O	283	287	five
O	288	293	years
O	294	299	after
O	300	309	diagnosis
O	310	313	but
O	314	317	the
O	318	328	transition
O	329	333	from
O	334	342	hospital
O	342	343	-
O	343	348	based
O	349	353	care
O	354	356	to
O	357	363	health
O	364	368	self
O	368	369	-
O	369	379	management
O	380	383	and
O	384	388	self
O	388	389	-
O	389	397	efficacy
O	398	401	can
O	402	404	be
O	405	414	difficult
O	414	415	.

O	416	420	Text
O	421	430	messaging
O	431	439	programs
O	440	445	offer
O	446	447	a
O	448	454	simple
O	455	458	and
O	459	465	proven
O	466	469	way
O	470	472	to
O	473	480	provide
O	481	488	support
O	489	491	to
O	492	498	people
O	499	503	with
O	504	511	chronic
O	512	520	diseases
O	520	521	.

O	522	526	This
O	527	532	study
O	533	537	aims
O	538	540	to
O	541	545	test
O	546	549	the
O	550	563	effectiveness
O	564	566	of
O	567	568	a
O	569	573	text
O	574	581	message
O	582	589	support
O	590	597	program
O	598	600	at
O	601	610	improving
O	611	616	women
O	616	617	'
O	617	618	s
O	619	625	health
O	626	630	self
O	630	631	-
O	631	639	efficacy
O	639	640	,
O	641	644	and
O	645	653	physical
O	654	657	and
O	658	664	mental
O	665	671	health
O	672	680	outcomes
O	681	686	after
O	687	693	breast
O	694	700	cancer
O	701	711	treatments
O	712	720	compared
O	721	723	to
B-control	724	729	usual
I-control	730	734	care
O	735	737	at
O	738	739	6
O	739	740	-
O	740	746	months
O	747	750	and
O	751	753	to
O	754	764	understand
O	765	768	the
O	769	777	barriers
O	778	781	and
O	782	790	enablers
O	791	793	to
O	794	804	widespread
O	805	819	implementation
O	819	820	.

O	821	827	Single
O	827	828	-
O	828	833	blind
O	834	844	randomised
O	845	852	control
O	853	858	trial
O	859	860	(
O	860	863	RCT
O	863	864	;
O	865	866	N
O	867	868	=
B-total-participants	869	872	160
O	872	873	)
O	874	883	comparing
O	884	885	a
O	886	890	text
O	891	898	message
O	899	906	support
O	907	919	intervention
O	920	922	to
O	923	928	usual
O	929	933	care
O	934	936	in
B-eligibility	937	942	women
I-eligibility	943	947	with
I-eligibility	948	954	breast
I-eligibility	955	961	cancer
O	962	963	(
O	963	972	recruited
O	973	977	from
O	978	979	a
O	980	985	large
O	986	994	tertiary
O	995	1003	referral
O	1004	1012	hospital
O	1013	1015	in
B-location	1016	1022	Sydney
I-location	1022	1023	,
I-location	1024	1033	Australia
O	1033	1034	)
O	1034	1035	.

O	1036	1039	The
O	1040	1052	intervention
O	1053	1058	group
O	1059	1063	will
O	1064	1071	receive
O	1072	1073	a
O	1074	1077	six
O	1077	1078	-
O	1078	1083	month
O	1084	1088	text
O	1089	1096	message
O	1097	1104	support
O	1105	1112	program
O	1112	1113	,
O	1114	1119	which
O	1120	1128	consists
O	1129	1131	of
O	1132	1136	semi
O	1136	1137	-
O	1137	1149	personalised
O	1149	1150	,
O	1151	1161	supportive
O	1161	1162	,
O	1163	1172	lifestyle
O	1172	1173	-
O	1173	1180	focused
O	1181	1185	text
O	1186	1194	messages
O	1195	1196	(
O	1196	1197	4
O	1198	1206	messages
O	1206	1207	/
O	1207	1211	week
O	1211	1212	)
O	1213	1215	in
O	1216	1224	addition
O	1225	1227	to
O	1228	1233	usual
O	1234	1238	care
O	1238	1239	.

O	1240	1243	The
O	1244	1251	control
O	1252	1257	group
O	1258	1262	will
O	1263	1270	receive
B-control	1271	1276	usual
I-control	1277	1281	care
O	1282	1289	without
O	1290	1293	the
O	1294	1298	text
O	1299	1306	message
O	1307	1314	program
O	1314	1315	.

O	1316	1324	Outcomes
O	1325	1329	will
O	1330	1332	be
O	1333	1341	assessed
O	1342	1344	at
O	1345	1346	6
O	1346	1347	-
O	1347	1353	months
O	1353	1354	.

O	1355	1358	The
O	1359	1366	primary
O	1367	1374	outcome
O	1375	1377	is
B-outcome-Measure	1378	1384	change
I-outcome-Measure	1385	1387	in
I-outcome-Measure	1388	1392	self
I-outcome-Measure	1392	1393	-
I-outcome-Measure	1393	1401	efficacy
I-outcome-Measure	1402	1405	for
I-outcome-Measure	1406	1414	managing
I-outcome-Measure	1415	1422	chronic
I-outcome-Measure	1423	1430	disease
O	1430	1431	.

O	1432	1441	Secondary
O	1442	1450	outcomes
O	1451	1458	include
B-outcome-Measure	1459	1465	change
I-outcome-Measure	1466	1468	in
I-outcome-Measure	1469	1477	clinical
I-outcome-Measure	1478	1486	outcomes
I-outcome-Measure	1487	1488	(
I-outcome-Measure	1488	1492	body
I-outcome-Measure	1493	1497	mass
I-outcome-Measure	1498	1503	index
I-outcome-Measure	1503	1504	)
O	1504	1505	,
B-outcome-Measure	1506	1515	lifestyle
I-outcome-Measure	1516	1524	outcomes
I-outcome-Measure	1525	1526	(
I-outcome-Measure	1526	1534	physical
I-outcome-Measure	1535	1543	activity
I-outcome-Measure	1544	1550	levels
I-outcome-Measure	1550	1551	,
I-outcome-Measure	1552	1559	dietary
I-outcome-Measure	1560	1570	behaviours
I-outcome-Measure	1570	1571	)
O	1571	1572	,
B-outcome-Measure	1573	1577	mood
I-outcome-Measure	1578	1579	(
I-outcome-Measure	1579	1589	depression
I-outcome-Measure	1590	1593	and
I-outcome-Measure	1594	1601	anxiety
I-outcome-Measure	1602	1608	scales
I-outcome-Measure	1608	1609	)
O	1609	1610	,
B-outcome-Measure	1611	1618	quality
I-outcome-Measure	1619	1621	of
I-outcome-Measure	1622	1626	life
O	1626	1627	,
B-outcome-Measure	1628	1640	satisfaction
I-outcome-Measure	1641	1645	with
O	1645	1646	,
O	1647	1650	and
B-outcome-Measure	1651	1661	usefulness
I-outcome-Measure	1662	1664	of
I-outcome-Measure	1665	1668	the
I-outcome-Measure	1669	1681	intervention
O	1681	1682	.

O	1683	1691	Analyses
O	1692	1696	will
O	1697	1699	be
O	1700	1709	performed
O	1710	1712	on
O	1713	1716	the
O	1717	1726	principle
O	1727	1729	of
O	1730	1739	intention
O	1739	1740	-
O	1740	1742	to
O	1742	1743	-
O	1743	1748	treat
O	1749	1751	to
O	1752	1759	examine
O	1760	1771	differences
O	1772	1779	between
O	1780	1792	intervention
O	1793	1796	and
O	1797	1804	control
O	1805	1811	groups
O	1811	1812	.

O	1813	1817	This
O	1818	1823	study
O	1824	1828	will
O	1829	1833	test
O	1834	1836	if
O	1837	1838	a
O	1839	1847	scalable
O	1848	1851	and
O	1852	1856	cost
O	1856	1857	-
O	1857	1866	effective
O	1867	1871	text
O	1871	1872	-
O	1872	1881	messaging
O	1882	1894	intervention
O	1895	1897	is
O	1898	1907	effective
O	1908	1910	at
O	1911	1920	improving
O	1921	1926	women
O	1926	1927	'
O	1927	1928	s
O	1929	1935	health
O	1936	1940	self
O	1940	1941	-
O	1941	1949	efficacy
O	1949	1950	,
O	1951	1953	as
O	1954	1958	well
O	1959	1961	as
O	1962	1970	physical
O	1971	1974	and
O	1975	1981	mental
O	1982	1988	health
O	1989	1997	outcomes
O	1997	1998	.

O	1999	2007	Moreover
O	2007	2008	,
O	2009	2013	this
O	2014	2019	study
O	2020	2024	will
O	2025	2032	provide
O	2033	2042	essential
O	2043	2054	preliminary
O	2055	2059	data
O	2060	2062	to
O	2063	2070	bolster
O	2071	2072	a
O	2073	2078	large
O	2079	2090	multicentre
O	2091	2094	RCT
O	2095	2097	to
O	2098	2109	helpsupport
O	2110	2116	breast
O	2117	2123	cancer
O	2124	2133	survivors
O	2134	2144	throughout
O	2145	2153	recovery
O	2154	2157	and
O	2158	2164	beyond
O	2164	2165	.

O	2166	2175	Australia
O	2176	2179	New
O	2180	2187	Zealand
O	2188	2196	Clinical
O	2197	2203	Trials
O	2204	2212	Registry
O	2213	2214	(
O	2214	2220	ANZCTR
O	2220	2221	)
O	2222	2228	number
O	2229	2248	ACTRN12618002020268
O	2249	2250	,
O	2251	2253	17
O	2254	2262	December
O	2263	2267	2018
O	2267	2268	.
